A look at where we’re headed.
Virus Briefing

June 13, 2022

An informed guide to the pandemic, with the latest developments and expert advice about prevention and treatment.

(Was this email forwarded to you? Sign up here.)

The New York Times
Where are we headed? Zack Wittman for The New York Times

The pandemic outlook

The U.S. is in a peculiar moment in the pandemic.

The nation is still averaging over 100,000 cases a day as the latest virus wave appears to be making its way westward. Yet many Americans seem to be meeting this latest wave with a shrug. Could this be the new normal?

To help us reflect on where we are and where we’re going, I connected with Zeynep Tufekci, a sociologist who has written extensively on Covid for The Times’s Opinion section.

As a society, where are we in the pandemic?

I think the official messaging and our policy remain muddled and confusing, and that’s causing a lot of polarization. There are many questions that remain unanswered and a lack of clarity about the future steps. For example, it’s June 2022 and we still don’t have clarity on updating our vaccines for fall or for vaccines for the youngest. We don’t have the kind of research, clarity and steps needed to address long Covid, either.

In response, some people are very anxious, some people are wondering how much to worry and some people have basically tuned out. And I’m not sure I could blame any group because at this moment, navigating the pandemic is kind of like a build-your-own-adventure game.

What do you think the next phase of the pandemic will look like?

There are many possible paths. The worst-case scenario would be that we get a variant that causes significant amounts of severe disease even among the vaccinated or those with prior infections. If this happens, and we haven’t prepared to quickly update our vaccines and administer them widely and globally, it could be a pretty grim scenario.

It’s also possible that we just kind of sputter along: There isn’t a new variant that represents a huge jump, at least in terms of causing acute illness. But in combination with waning vaccine effectiveness, especially among the elderly whose immune systems are weaker, it settles into something like the disease burden of influenza. That’s also terrible. Influenza itself causes an incredible amount of suffering every year, and it would further strain our already strained health care system.

The ideal scenario for vaccines is we update the vaccines, we vaccinate children and we vaccinate globally. But we shouldn’t stop there. We could also do many other things that would benefit everyone. For example, immunocompromised people are especially susceptible to generating variants because they can have very long-term infections. There are now therapeutics that should be used globally and equitably. And a large number of people with H.I.V. remain undertreated around the world, and thus immunocompromised. Extending treatment to them is both morally right and beneficial.

What else is the government not doing that it should?

There’s now a much better understanding of airborne transmission of respiratory diseases. If we got our act together, we could do for indoor air sanitation something similar to what we did to water after discovering waterborne diseases, in terms of regulating it to make it safer with better air cleaning filters, ventilation and other methods. We would see benefits against all the other respiratory viruses that are airborne too. It would be costly at first, but we would recoup that cost because illness is very costly — in terms of the human suffering but also financially.

How do you feel about the moment we are in?

We’re not in a good place, even though we could be. I am very despondent about the dysfunctional global and national response, and lack of clear next steps. We are not able to do things that are within the reach of countries like ours with the amount of science and wealth we have, let alone globally.

When you have a virus or some problem and you don’t have an effective response, that is tragic. But it’s a different kind of tragic when we have so many things we could be doing but we just can’t get our act together. It feels like we’re living a bad chapter in a history book that ends with “aaand that’s why they screwed it up even though they didn’t have to.”

Leonardo Santamaria

Reinfection 101

With Omicron and its subvariants causing a surge of cases, it seems as if everyone knows people who have had Covid again after a recent infection. To help us understand what’s going on, The Times’s Well desk recently answered some basic questions about reinfection. Here’s an excerpt.

How long does immunity last?

Before Omicron, reinfections were rare. One study estimated that a bout with Delta or an earlier coronavirus strain was roughly 90 percent effective in preventing a re-infection in both vaccinated and unvaccinated people. After Omicron emerged, prior infections provided only about 50 percent protection against reinfection.

You can even get sick with one of the newer Omicron subvariants after getting over a different version of it. In a study published in February that has not yet been peer-reviewed, scientists from Denmark found that some people got reinfected with the BA.2 sublineage of Omicron as soon as 20 days after they got infected with the original Omicron BA.1.

Will subsequent infections be more or less severe?

The good news is that your body can call on immune cells, like T cells and B cells, which can take a few days to get activated and start working but tend to remember how to battle the virus. The result is that second or third infections are likely to be shorter and less severe.

What can you do to reduce your risk of reinfection?

Get vaccinated and boosted. The vaccines will bolster your antibody levels, and research shows that they are effective in preventing severe outcomes if you get sick again.

In Opinion, a professor of immunology argues that new tools can make our immunity to the virus even stronger.

How has RTO been for you?

Many office employees across the U.S. have been called back to the workplace. We want to know how that’s going.

We’re asking readers who have gone back: What has the experience been like so far? And what’s your advice for adjusting to the routines? Let us know by filling out this form. We may use your response in an upcoming newsletter.

What else we’re following

What you’re doing

“How are you?” “Fine,” I say. It’s a lie, of course. But it’s not about concealing truths as much as having secrets. Maybe we’re all just floating on the surface. I wish I could tell you this: I’m not fine. I’m not busy. I’m watching hours of TV, sometimes the same sitcom rerun over and over, until I’m visited by their characters in my sleep. I need air. I go for a walk, but after two years of roaming to Chinatown and back, I have no patience. I want a destination. I want to hike up the hill to the pond. I want to see the lilies open on their pads as the sun rises. But I’m also tired of aloneness. Two years and three months have passed. At first, I heard the sparrows’ song and that was almost enough. At 7 p.m. I’d go on my balcony and bang on a pot lid with a spaghetti server and cheer along with the whole neighborhood. That was my community. While thousands were dying, we had hope. But now it’s lost. So if you run into me on the street and I say I’m fine, don’t take my lie personally. Like you, I’m just keeping a secret.

— Linda Schwartz, New York, N.Y.

Let us know how you’re dealing with the pandemic. Send us a response here, and we may feature it in an upcoming newsletter.

Email your thoughts to briefing@nytimes.com. Did a friend forward you the briefing? Sign up here.

Need help? Review our newsletter help page or contact us for assistance.

You received this email because you signed up for Virus Briefing from The New York Times.

To stop receiving Virus Briefing, unsubscribe. To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings. To opt out of updates and offers sent from The Athletic, submit a request.

Subscribe to The Times

Connect with us on:

facebooktwitterinstagram

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

The New York Times Company. 620 Eighth Avenue New York, NY 10018